Cranswick (CWK) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
19 May, 2026Executive summary
Achieved 9.5% revenue growth and 8.3% UK food volume growth year-over-year, driven by strong operational performance, strategic investments, and record Christmas trading.
Adjusted operating margin rose to 7.9%, supported by operational leverage and disciplined cost control.
Maintained 36 years of consecutive annual dividend growth, increasing the final dividend by 12.5%.
Significant capital investments and acquisitions, including Blakemans, JSR Genetics, and Fridaythorpe feed mill, enhanced vertical integration and supply chain efficiency.
Trading in the early part of the new financial year is in line with expectations, with robust demand and expanding growth opportunities.
Financial highlights
Reported revenue reached GBP 2,982.5 million, up 9.5% year-over-year.
Adjusted operating profit increased by 14.5% to GBP 237 million; adjusted profit before tax was GBP 220 million, up 11.2%.
Adjusted EPS increased 10.4% to 301.7p; dividend per share up 11.4% to GBP 1.125.
Free cash flow rose 25.7% to GBP 268.4 million; free cash conversion at 120.6%.
Net debt (excluding leases/IFRS 16) was GBP 65.0 million, with leverage at 0.2x.
Outlook and guidance
Continued investment in capacity, automation, and efficiency, including GBP 56 million for poultry expansion and GBP 100 million for pork.
Positive outlook for all product categories, supported by long-term consumer partnerships and innovation.
Medium-term targets reaffirmed: mid-single digit revenue growth, operating margin ~7.5%, ROCE upper teens, leverage <2x.
Latest events from Cranswick
- Record Christmas trading and strong Q3 growth drive profit outlook to upper market range.CWK
Q3 2026 TU27 Jan 2026 - Adjusted profit before tax up 17.4% on strong volume growth and margin expansion.CWK
H1 202512 Jan 2026 - Double-digit revenue and profit growth, record investment, and strong outlook for the year.CWK
H1 202625 Nov 2025 - Record revenue and margin growth, strong investment, and 35 years of dividend increases.CWK
H2 202519 Nov 2025 - Revenue up 9.7% year-over-year, with strong growth and positive outlook maintained.CWK
Q1 2026 TU28 Jul 2025 - Upgraded FY25 outlook driven by strong trading, volume growth, and ongoing investment.CWK
Trading Update13 Jun 2025 - Q1 revenue up 6.7% with strong UK demand and continued investment in capacity.CWK
Q1 2025 TU13 Jun 2025 - Record Q3 growth and JSR Genetics acquisition drive supply security and efficiency.CWK
Q3 2025 TU6 Jun 2025 - Upgraded targets and major investments drive growth in premium food categories and efficiency.CWK
CMD 20256 Jun 2025